secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turn Therapeutics Inc. (TTRX)
CIK:        0002023016
Form:       8-K
Filed at:   2026-08-18T12:30:15+00:00
Accession:  0001213900-26-091002
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Turn Therapeutics issues 579,664 shares to GEM on cashless warrant exercise
---------------------------------------------------------------------------

- On Aug 13, 2026, GEM exercised warrant in full via cashless provision; company issued 579,664 common shares.
- Warrant originally covered 1,192,207 shares (4% fully diluted) at $5.03 exercise price, dated Oct 8, 2025.
- Shares issued under Section 4(a)(2) exemption; GEM represented as accredited investor.
- Exercise triggered because per-share market value exceeded $5.03 warrant price.
- No new capital raised; dilution of ~0.5% of fully diluted shares (579,664 vs. prior total).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/0001213900-26-091002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/ea0302512-8k_turn.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-091002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer